/ EN
2026-06-13 00:00 China Clinical Implantation & Procedure Translated from EN

Xiangya IMIE Retina Trial Restores 0.1 Vision

Summary In Xiangya Hospital's invasive IMIE smart retina trial, a 61-year-old fully blind patient reportedly reached 0.03 stable and 0.1 best visual acuity, walking indoors unaided.
Why it matters China's second publicly disclosed visual BCI clinical case, with quantified 0.03-0.1 acuity outcomes that corroborate the Zhejiang implant and show homegrown vision restoration entering multi-site clinical validation

BCIwiki (bciwiki.com) — An invasive brain-computer interface trial of the 'IMIE smart retina', led by Professor Xu Huizhuo's team at Xiangya Hospital of Central South University (中南大学湘雅医院), has produced results, according to a June 13, 2026 report by PharmCube: a 61-year-old fully blind patient received the implant on April 23, 2026 and recovered smoothly.

According to the report, the patient — diagnosed with retinitis pigmentosa at age 40 — can now clearly recognize standard characters on an E-chart, with stable visual acuity of 0.03 and best acuity of 0.1, and can walk indoors and pass through doorways unaided. The report does not name a developer company for the IMIE smart retina, describing it as independently developed by the research team. All reported outcomes are attributed to the news report, with long-term results pending follow-up.

Compiled by BCIwiki from public sources

Sources · 1

Xiangya Hospital, Central South University timeline

2026-08 BCI Plans Across 10 Chinese Provinces All Target 2030, Only Zhejiang and Beijing Reimburse All entries →
Read original ↗
Suggest a correction Revisions · none / EN
© 2026 BCIwiki.com Digest Topics Tips Subscribe Revisions About